Works about LOPINAVIR-ritonavir
Results: 394
A Direct Comparison of the Effects of the Antiretroviral Drugs Stavudine, Tenofovir and the Combination Lopinavir/Ritonavir on Bone Metabolism in a Rat Model.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Safety profile of COVID-19 drugs in a real clinical setting.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 5, p. 733, doi. 10.1007/s00228-021-03270-2
- By:
- Publication type:
- Article
Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 9, p. 1297, doi. 10.1007/s00228-021-03108-x
- By:
- Publication type:
- Article
Reply to the letter to the Editor "Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts".
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 389, doi. 10.1007/s00228-020-03020-w
- By:
- Publication type:
- Article
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients.
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, n. 2, p. 143, doi. 10.1007/s00228-010-0904-4
- By:
- Publication type:
- Article
Key insights into recent advances and challenges in COVID-19 management.
- Published in:
- Discover Public Health, 2025, v. 22, n. 1, p. 1, doi. 10.1186/s12982-024-00364-x
- By:
- Publication type:
- Article
The interactions between COVID-19 drugs and psychotropic agents.
- Published in:
- European Psychiatry, 2021, v. 64, p. S15, doi. 10.1192/j.eurpsy.2021.63
- By:
- Publication type:
- Article
High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5567332
- By:
- Publication type:
- Article
Both Chloroquine and Lopinavir/Ritonavir Are Ineffective for COVID-19 Treatment and Combined Worsen the Pathology: A Single-Center Experience with Severely Ill Patients.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/8821318
- By:
- Publication type:
- Article
AI-Aided Design of Novel Targeted Covalent Inhibitors against SARS-CoV-2.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 6, p. 746, doi. 10.3390/biom12060746
- By:
- Publication type:
- Article
Does efavirenz replacement improve neurological function in treated HIV infection?
- Published in:
- HIV Medicine, 2017, v. 18, n. 9, p. 690, doi. 10.1111/hiv.12503
- By:
- Publication type:
- Article
Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir.
- Published in:
- HIV Medicine, 2016, v. 17, n. 5, p. 340, doi. 10.1111/hiv.12314
- By:
- Publication type:
- Article
Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates.
- Published in:
- HIV Medicine, 2016, v. 17, n. 1, p. 28, doi. 10.1111/hiv.12277
- By:
- Publication type:
- Article
Improved serum cholesterol in paediatric patients switched from suppressive lopinavir-based therapy to boosted darunavir or atazanavir: an 18-month retrospective study.
- Published in:
- HIV Medicine, 2014, v. 15, n. 10, p. 635, doi. 10.1111/hiv.12180
- By:
- Publication type:
- Article
Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial
- Published in:
- HIV Medicine, 2013, v. 14, n. 1, p. 49, doi. 10.1111/j.1468-1293.2012.01060.x
- By:
- Publication type:
- Article
FACILE SYNTHESIS OF PROCESS RELATED IMPURITIES OF LOPINAVIR.
- Published in:
- Rasayan Journal of Chemistry, 2016, v. 9, n. 2, p. 203
- By:
- Publication type:
- Article
The "New" Problem of Humanity: New Coronavirus (2019-nCoV / COVID-19) Disease.
- Published in:
- Medical Journal of Bakirkoy, 2020, v. 16, n. 1, p. 1, doi. 10.5222/BMJ.2020.22931
- By:
- Publication type:
- Article
Favipiravir Effects on the Control of Clinical Symptoms of Hospitalized COVID-19 Cases: An Experience with Iranian Formulated Dosage Form.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2021, v. 20, n. 4, p. 1, doi. 10.22037/ijpr.2021.115510.15401
- By:
- Publication type:
- Article
Consultation psychiatry in COVID‐19 patients: Lopinavir/ritonavir interactions with main psychiatric drugs.
- Published in:
- Psychiatry & Clinical Neurosciences, 2021, v. 75, n. 4, p. 145, doi. 10.1111/pcn.13205
- By:
- Publication type:
- Article
A Case Study Supporting Lack of SARS-CoV-2 Spread to a 3-Month Old Infant Through Exclusive Breastfeeding.
- Published in:
- Journal of Human Lactation, 2021, v. 37, n. 2, p. 269, doi. 10.1177/0890334421991072
- By:
- Publication type:
- Article
SARS CoV-2 (COVID-19) Current Pharmacotherapy for Mother and Infant.
- Published in:
- Neonatal Network, 2021, v. 40, n. 3, p. 175, doi. 10.1891/11-T-737
- By:
- Publication type:
- Article
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Computed tomography manifestations of COVID-19 pneumonia.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 5, p. 2608, doi. 10.3390/ijms22052608
- By:
- Publication type:
- Article
Combination of long‑acting HIV fusion inhibitor albuvirtide and LPV/r showed potent efficacy in HIV‑1 patients.
- Published in:
- AIDS Research & Therapy, 2016, v. 13, p. 1, doi. 10.1186/s12981-016-0091-1
- By:
- Publication type:
- Article
Sensory neuropathy and metabolic risk factors in human immune deficiency virus infected South Africans receiving protease inhibitors.
- Published in:
- AIDS Research & Therapy, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12981-015-0073-8
- By:
- Publication type:
- Article
HIV post exposure prophylaxis induced bicytopenia: a case report.
- Published in:
- AIDS Research & Therapy, 2014, v. 11, p. 2, doi. 10.1186/1742-6405-11-11
- By:
- Publication type:
- Article
Association of lopinavir concentrations with plasma lipid or glucose concentrations in HIV-infected South Africans: a cross sectional study.
- Published in:
- AIDS Research & Therapy, 2012, v. 9, p. 32, doi. 10.1186/1742-6405-9-32
- By:
- Publication type:
- Article
Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure.
- Published in:
- AIDS Research & Therapy, 2012, v. 9, p. 8, doi. 10.1186/1742-6405-9-8
- Publication type:
- Article
The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
- Published in:
- AIDS Research & Therapy, 2011, v. 8, p. 7, doi. 10.1186/1742-6405-8-7
- By:
- Publication type:
- Article
Drug repurposing in the era of COVID-19: a call for leadership and government investment.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Nevirapine- Versus Lopinavir/Ritonavir-Based Initial Therapy for HIV-1 Infection among Women in Africa: A Randomized Trial.
- Published in:
- PLoS Medicine, 2012, v. 9, n. 6, p. 1, doi. 10.1371/journal.pmed.1001236
- By:
- Publication type:
- Article
Anesthesia for children taking COVID‐19 antiviral drugs.
- Published in:
- Pediatric Anesthesia, 2022, v. 32, n. 4, p. 579, doi. 10.1111/pan.14410
- By:
- Publication type:
- Article
Evaluating the Efficacy and Safety of the Existing Repurposed Pharmacological Agents for Treating COVID-19: A Meta-analysis and Systematic Review of Clinical Trials.
- Published in:
- Indian Journal of Critical Care Medicine, 2020, v. 24, n. 11, p. 1106, doi. 10.5005/jp-journals-10071-23664
- By:
- Publication type:
- Article
A Multicenter Questionnaire-Based Study to Know the Awareness and Medical Treatment Plan of Physicians Involved in the Management of COVID-19 Patients.
- Published in:
- Indian Journal of Critical Care Medicine, 2020, v. 24, n. 10, p. 919
- By:
- Publication type:
- Article
Coronavirus Disease 2019 Treatment: It is Time for Stewardship!
- Published in:
- Indian Journal of Critical Care Medicine, 2020, v. 24, n. 10, p. 895, doi. 10.5005/jp-journals-10071-23622
- By:
- Publication type:
- Article
Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 427, doi. 10.1007/s10557-020-07070-1
- By:
- Publication type:
- Article
Discovery of potent Covid‐19 main protease inhibitors using integrated drug‐repurposing strategy.
- Published in:
- Biotechnology & Applied Biochemistry, 2021, v. 68, n. 4, p. 712, doi. 10.1002/bab.2159
- By:
- Publication type:
- Article
Baseline PI susceptibility by HIV-1 Gag-protease phenotyping and subsequent virological suppression with PI-based second-line ART in Nigeria.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Randomized controlled trial of the tolerability and completion of maraviroc compared with Kaletra® in combination with Truvada® for HIV post-exposure prophylaxis (MiPEP Trial).
- Published in:
- 2017
- By:
- Publication type:
- journal article
A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Residual HIV-1 replication may impact immune recovery in patients on first-line lopinavir/ritonavir monotherapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 9, p. 2627, doi. 10.1093/jac/dkv138
- By:
- Publication type:
- Article
Monotherapy with boosted PIs as an ART simplification strategy in clinical practice.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 4, p. 1124, doi. 10.1093/jac/dku509
- By:
- Publication type:
- Article